Different anatomic and physiological changes occur in the lung of aging people that can
affect pulmonary functions, and different pulmonary diseases, including deadly diseases …

Mesenchymal stem cells form a population of self‐renewing, multipotent cells that can be
isolated from several tissues. Multiple preclinical studies have demonstrated that the …

An increasing number of studies demonstrate that administration of either conditioned media
(CM) or extracellular vesicles (EVs) released by mesenchymal stromal cells (MSCs) derived …

Summary 2018 was the year of the first marketing authorization of an allogeneic stem cell
therapy by the European Medicines Agency. The authorization concerns the use of …

The severe cases of Coronavirus Disease 2019 (COVID-19) frequently exhibit excessive
inflammatory responses, acute respiratory distress syndrome (ARDS), coagulopathy, and …

Acute respiratory distress syndrome/acute lung injury (ALI) was described in 1967. The
uncontrolled inflammation is a central issue of the syndrome. The regulatory T cells (Tregs) …

Several experimental studies have provided evidence that bone-marrow derived
mesenchymal stem (stromal) cells (MSC) may be effective in treating critically ill surgical …

The COVID-19 pandemic has caused havoc all around the world. The causative agent of
COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in …

Rationale: Aging is characterized by functional impairment and reduced capacity to respond
appropriately to environmental stimuli and injury. With age, there is an increase in the …

Mesenchymal stromal cells (MSCs) have been investigated as a treatment for various
inflammatory diseases because of their immunomodulatory and reparative properties …